Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair... see more

TSXV:RP - Post Discussion

View:
Post by Genie29j on Jan 25, 2023 2:39pm

Loading up

As we inch closer to the May judgement with Shiseido- I will be curious how that affects the stock price. I'm likely a buyer in April hoping for a positive outcome in the chance Replicel & Shiseido come to an agreement earlier and/or a favorable outcome 

I'm still a firm believer of the following in the stock price
1. The device $1-2
2. A positive outcome with Shiseido $2-3 (incremental).
3. If the data is REALLY good from Shiseido strap in, I trust the Replicel team will get investors galore wanting a piece of it. I see a  $12-15 stock price from there

many "if's" remain - but that's what you get when you invest in a pre revenue company. I trust the fact Andrew and team are feeling awfully confident given their latest investments 

but "when" it hits, better take a few days off work bc there's no chance you'll be able to concentrate on anything other than all the money you're raking in 

here's to a great 2023 for Replicel and our shares.
Comment by Ingiboy on Jan 25, 2023 8:41pm
Love the optimism JC !   Just a point of clarity.  The hearing with Replicel & Shiseido is on May 29th.  The judgement could take up to 60 days after the hearing. I am still of the opinion it will not get to this hearing date.  Now that both sides have each other's deposition which is now in the hands of the Arbitrator the side with the weakest defence will be advised  ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities